IVUS-Guided Zero-Contrast PCI in CKD Patients: Safety and Short-Term Outcome in Patients with Complex Demographics and/or Lesion Characteristics

Table 1

Baseline clinical characteristics.

Baseline characteristics	Overall group (n = 15)
Age (mean ± SD) (years)	70.0 ± 11.0
Male	15 (100%)
Hypertension	13 (86.7%)
Diabetes mellitus	13 (86.7%)
Dyslipidemia	10 (66.7%)
Previous PCI	4 (26.7%)
Previous CAD	5 (33.3%)
Initial hospital presentation
SIHD	7 (46.6%)
Unstable angina	2 (13.3%)
NSTEMI	4 (26.6%)
STEMI (non–culprit lesion)	2 (13.3%)
LVEF (mean ± SD)	42.4 ± 11.6
LVEF (%)
>50	4 (26.6%)
40–49	6 (40%)
<40	5 (33.3%)
Serum creatinine (mg/dL) (mean ± SD)	2.6 ± 1.3
eGFR (mL/min/1.73 m^2) (mean ± SD)	30.8 ± 7.3
BMC2 CIN risk (%) (mean ± SD)	15.3 ± 8.3
BMC2 dialysis risk (%) (mean ± SD)	2.1 ± 1.1

All data are presented as n (%) unless otherwise specified. BMC : Blue Cross Blue Shield of Michigan Cardiovascular Consortium; CIN : contrast-induced nephropathy; eGFR : estimated glomerular filtration rate; LVEF : left ventricular ejection fraction; NSTEMI : non-ST-elevation myocardial infarction; PCI : percutaneous coronary intervention; SD : standard deviation; SIHD : stable ischemic heart disease; STEMI : ST-elevation myocardial infarction.